Breakthrough for MS treatment.

A new study, published in the New England Medical Journal shows that a drug produced by Genzyme and partner Bayer AG to combat leukaemia considerably reduces the risk of relapse in early Multiple Sclerosis. Scientists at Cambridge University hope the research will lead to improved treatment for the many sufferers of MS worldwide.

CK Science has a number of vacancies in scientific research and development, click here for more details.

Posted in: Jobs, News
CK Logo in place of featured image